How to Choose a Reproductive Endocrinologist

You have a referral, or a list of three clinics, or a single name your OB-GYN scribbled on a card. You want to know what separates a strong reproductive endocrinologist from a busy one, what the headline clinic success rates actually mean, and whether you can switch later without losing ground.

The right reproductive endocrinologist (RE) is not the one with the highest billboard success rate. It is a board-certified subspecialist whose practice matches your diagnosis (whether that is PCOS, male factor, recurrent loss, or diminished reserve), whose communication style fits how you make decisions, and whose lab and monitoring logistics actually work for your life and your work hours.

This is a pillar post that pulls together the credential checks, the success-rate caveats, the diagnosis-specific fit questions, the logistics that often get skipped, and the cost questions that should not. I will also flag the searches that bring people here, including the common question of how much does a reproductive endocrinologist make, because understanding the training pipeline is part of understanding who you are walking into a room with.

What is a reproductive endocrinologist?

A reproductive endocrinologist is a board-certified obstetrician-gynaecologist who has completed a three-year subspecialty fellowship in Reproductive Endocrinology and Infertility (REI) after residency. The training pipeline runs:

• Four years of medical school
• Four years of OB-GYN residency
• Three years of REI fellowship

In the United States, the certifying body is the American Board of Obstetrics and Gynecology (ABOG), with subspecialty certification in REI.⁷ In the United Kingdom, the equivalent is a Certificate of Completion of Training (CCT) in Reproductive Medicine, recorded on the GMC specialist register. In Australia and New Zealand, it is the RANZCOG CREI subspecialty certification.

This is the answer to the recurring question of what do reproductive endocrinologist do and duties of a reproductive endocrinologist. They diagnose and treat infertility and reproductive endocrine disorders: ovulation induction, IUI, IVF, donor protocols, fertility preservation, recurrent pregnancy loss, endometriosis-related infertility, and the management of conditions like PCOS, premature ovarian insufficiency, and pituitary dysfunction that affect reproduction. They are not the same as a general OB-GYN, a fertility-aware family physician, or a "fertility coach" without medical credentials. They are also not the same as a clinical embryologist (lab side) or a urologist (male side), although you will likely see all three in a full workup.

On the how to become a reproductive endocrinologist and how much does a reproductive endocrinologist make questions: total training is roughly eleven years post-undergrad. US salaries vary widely with practice setting, partnership, and case mix, but are publicly tracked. The relevance for you as a patient is that the long training pipeline is why subspecialty certification, not just "fertility specialist" marketing, is the credential to check.

How do you verify an RE's credentials before booking?

Before you book a consultation, fifteen minutes of credential checking is worth it. The marketing on a clinic website does not always match the registry.

• United States: verify the clinician on the ABOG/ABMS register, check whether the clinic is a Society for Assisted Reproductive Technology (SART) member, and look up ASRM membership.
• United Kingdom: the HFEA register lists every licensed clinic and its inspection status. The GMC specialist register confirms the clinician's CCT in Reproductive Medicine.
• Australia and New Zealand: the RANZCOG CREI subspecialty register confirms training. Clinics should be RTAC-accredited.
• Europe: ESHRE-affiliated clinics and country-specific specialist boards apply.

A clinic that advertises "fertility specialist" without verifiable subspecialty training is a flag. So is a clinic that does not list its accreditation status openly on its website.

This step is the answer to the question I have been asked many times about the reproductive endocrinologist and endocrinologist distinction. A general endocrinologist is trained in internal medicine and endocrine subspecialty; an RE is trained in obstetrics-gynaecology and REI subspecialty. They overlap in thyroid, prolactin, and PCOS, but the RE's training is specifically reproductive and includes the surgical and procedural side that a general endocrinologist does not have.

What do SART and HFEA success rates actually tell you?

US SART data and UK HFEA data are the most cited numbers in clinic marketing. They are also the most misinterpreted.

SART reports live-birth rates per egg retrieval and per transfer, broken down by patient age band. HFEA reports per-clinic live birth rates per embryo transferred, by age band. Both publish national-level summaries.²,³ The numbers are real and the reporting is mandatory, but a few things drive most of the variance between clinics.

Cohort selection: clinics that decline to treat poor-prognosis patients (low AMH, high BMI, advanced age, prior failed cycles) post higher headline numbers. A clinic that takes everyone has lower headline numbers but may be the right clinic for the patient who has been turned away elsewhere.

Patient mix: a clinic in a city with a younger patient population will look better than one with an older population, even with identical practice quality. The age-band breakdown helps, but does not fully control for this.

Practice patterns: a clinic that transfers two embryos when one is appropriate will have a higher per-transfer live birth rate at the cost of higher multiple-pregnancy rate, which is a worse clinical outcome. SART now reports single-embryo transfer rates partly because of this trade-off, and ASRM guidance is to minimise multiples.¹

For PCOS specifically, IVF success rates are not the right comparison. The relevant number is the clinic's ovulation-induction live-birth rate, the success of letrozole and gonadotropin cycles, which is rarely advertised because it does not appear on SART headline reports the way IVF does. Ask directly.

The honest interpretation: compare clinics within your own prognostic band, ask about their patient mix, and weigh the success rate alongside everything else here. Do not let a billboard make the decision.

How do you match a clinic to your diagnosis?

This is the section I push patients toward most often. Match matters more than overall reputation.

PCOS: pick a clinic that runs letrozole-first ovulation induction per the 2023 International Evidence-Based PCOS Guideline,⁴ with follicular ultrasound monitoring on-site. A clinic that pushes straight to IVF for ovulatory PCOS, or that defaults to clomiphene without considering letrozole, is not following current evidence. The how PCOS is diagnosed post covers what the clinic should be using for diagnosis itself.

Male factor: the clinic must have an on-site andrology lab certified for WHO 2021 semen analysis standards, plus a working relationship with a urologist or andrologist. A clinic that runs a single semen analysis and moves to IVF without further workup or urology referral is not following AUA/ASRM guidelines. The male fertility workup overview post details what a full male evaluation looks like.

Diminished ovarian reserve: look for clinics with experience in individualised stimulation protocols and DuoStim experience (two stimulations in one cycle). A clinic that uses the same high-dose protocol for everyone, regardless of what the AMH and FSH numbers say, is not optimising for this group.

Recurrent pregnancy loss: the clinic should have a defined RPL workup pathway (thyroid, prolactin, parental karyotype, antiphospholipid antibodies, uterine evaluation) and a maternal-fetal medicine partner for high-risk pregnancies that follow. A clinic that treats recurrent loss as "try again" is missing the point of the workup.

Endometriosis-related infertility: surgical capacity matters, either on-site minimally-invasive gyn surgery or a tight partnership with a gyn surgeon. Medical management alone is sometimes not enough.

Which clinic logistics questions do most people forget to ask?

This is the section that makes the biggest difference once treatment starts. I tell couples to ask about logistics before they ask about success rates, because the logistics are what break IVF and IUI cycles in real life.

• Cycle monitoring hours: early morning bloods and ultrasound, seven days a week including weekends and bank holidays? Treatment cycles do not respect calendar weeks. A clinic that closes on Sunday cannot time an IUI or IVF trigger properly.
• In-house lab versus send-out: turnaround time for estradiol and beta-hCG can be hours versus days, and that can change a same-day decision about dose or trigger timing.
• Embryology lab credentials: CAP and CLIA accreditation in the US; HFEA licensing in the UK; RTAC accreditation in Australia. Lab quality control is the single most under-discussed factor in IVF outcomes.
• After-hours contact path: who do you call at 9 pm on a Saturday if you start bleeding mid-cycle or have a severe medication reaction? "Call us Monday" is not an answer for fertility treatment.
• Nurse-coordinator-to-patient ratio: clinics that move volume well usually share this number when asked. A clinic where the nurse coordinator has 300 patients on her list is going to miss things.

These five questions reveal more about how a clinic actually runs than any headline success rate.

How do you judge an RE's communication style?

The clinical side is half the decision. The fit side is the other half.

Some questions I encourage couples to test in the first consultation:

• Does the RE present options with evidence, or hand you a single protocol without alternatives?
• When you ask why letrozole rather than clomiphene, or why this stimulation protocol rather than another, do you get a real explanation that references guidelines or studies, or do you get "this is what we do here"?
• Will they review your records with you before pushing to a treatment plan, or do they move to recommendation in the first ten minutes?
• Are partners welcome at every appointment, or treated as guests who can step in for specific moments?
• Cultural humility, language access, and LGBTQ+ inclusivity, if these matter to you, are reasonable to ask about directly.

There is no single "correct" communication style. Some patients want a clear protocol with minimal options to choose between. Some want to understand every decision. The mismatch comes when the patient wants engagement and the clinic provides protocol, or vice versa.

Cost transparency

Fertility treatment in any system costs money: time, copays, full self-pay, medication, monitoring, embryology, storage. A clinic that cannot provide an itemised fee schedule before you sign is making the cost decision for you.

What I tell couples to ask for in writing:

• Global cycle fee versus per-cycle fee structure
• Medication cost estimate (often a separate line, often the largest line)
• Monitoring fees (blood draws and ultrasounds, often billed per visit)
• Embryology and cryopreservation fees, plus annual storage costs
• Anaesthesia and procedure fees for retrieval and transfer
• Cost of repeat cycles within a defined package, if applicable

Some clinics offer per-cycle pricing, some offer multi-cycle packages with refund guarantees in defined circumstances. The maths changes substantially if there is a reasonable probability of needing more than one cycle. Insurance coordination, where applicable, should be handled by a financial counsellor at the clinic, not by you with the insurance company on hold.

Clinical-trial enrolment can offset cost meaningfully for the right patient. It is worth asking what trials are open and whether you might qualify.

When should you consider a second opinion?

Most clinicians expect and welcome second opinions for complex cases. You are not being disloyal by asking for one. Specific triggers I think warrant a second look:

• The plan moves to IVF before two adequate ovulation-induction cycles for ovulatory PCOS, without a documented reason such as severe male factor or tubal disease
• The male workup has not been done, or has been done with only one semen analysis
• Recurrent loss is in the history but no RPL workup has been ordered
• Communication has broken down to the point where you have stopped asking questions because you do not get answers

The when to get a second opinion post covers the how-to. The short version: keep your current clinic, request your records in writing (which you own), and book a second-opinion consultation elsewhere. Be transparent with both clinicians.

Can you switch fertility clinics mid-treatment?

If you do decide to switch, time matters.

Request records and embryology reports in writing. These are yours by right, in every system I have worked in. Time the switch between cycles, not in the middle of stimulation, unless a safety issue requires immediate change. Most clinics will refund unused medication or transfer it to a new clinic with appropriate documentation. Frozen embryos can be transferred between clinics, but the shipping logistics, consent paperwork, and storage arrangements need to be clarified before you sign with the new clinic.

The aim is to switch with full records and continuity, not to start over.

What to ask at the consult

A short list to take with you:

1. What is your live-birth rate for patients with my diagnosis and age, not your overall rate?
2. What is your typical first-line protocol for my situation (PCOS, male factor, DOR, RPL)?
3. Who actually does my monitoring, and who reads my ultrasounds?
4. What is your weekend and after-hours coverage, and who answers a 9 pm call?
5. What is the total cost for one cycle of the recommended treatment, itemised?

The questions to ask at your first fertility appointment post expands this into the full first-visit packet.

How does choosing an RE differ by health system?

The mechanics of choosing an RE differ between health systems. In the NHS, your GP refers, the choice of secondary-care fertility centre is often constrained by geography and waiting lists, and the option to switch involves either requesting a different consultant within the trust or asking your GP to refer to a different centre. In the private UK and US, direct booking is the norm and choice is wider, but verification and cost transparency become more on you.

The principles, credential verification, diagnosis-specific fit, infrastructure, communication, and cost clarity, apply equally across systems. The mechanics differ.

What's next

• For first-visit prep: questions to ask at your first fertility appointment
• For seeking a second look: when to get a second opinion on your fertility plan
• For PCOS workup the clinic should be following: how PCOS is diagnosed by Rotterdam criteria
• For the male partner side: male fertility workup overview
• Once you have a plan: the relevant treatment hub, medicated cycles, IUI, or IVF

Sources

1. Practice Committee of the American Society for Reproductive Medicine. Guidance on the limits to the number of embryos to transfer: a committee opinion. Fertility and Sterility 2021;116(3):651–654. https://doi.org/10.1016/j.fertnstert.2021.06.050
2. Society for Assisted Reproductive Technology. National Summary Report (current year). SART. https://www.sartcorsonline.com/
3. Human Fertilisation and Embryology Authority. Fertility treatment 2021: trends and figures. HFEA, 2023. https://www.hfea.gov.uk/about-us/publications/research-and-data/
4. Teede HJ, Tay CT, Laven JJE, Dokras A, Moran LJ, Piltonen TT, et al. Recommendations from the 2023 International Evidence-Based Guideline for the Assessment and Management of Polycystic Ovary Syndrome. Fertility and Sterility 2023;120(4):767–793. https://doi.org/10.1016/j.fertnstert.2023.07.025
5. National Institute for Health and Care Excellence. Fertility problems: assessment and treatment. NICE Clinical Guideline CG156, 2013 (updated 2017). https://www.nice.org.uk/guidance/cg156
6. Practice Committee of the American Society for Reproductive Medicine. Definitions of infertility and recurrent pregnancy loss: a committee opinion. Fertility and Sterility 2020;113(3):533–535. https://doi.org/10.1016/j.fertnstert.2019.11.025
7. American Board of Obstetrics and Gynecology. Subspecialty certification in Reproductive Endocrinology and Infertility. ABOG. https://www.abog.org/